KU-55933 and KU55933 Inhibit ATM Kinase to Escalate Cardiac Myocyte Apoptosis
Copy code to add this image to your page
Ataxia telangiectasia mutated (ATM) kinase is a high-molecular-weight serine/threonine protein kinase belonging to the phosphatidylinositol 3-kinase-related kinase (PIKK) family. Classically recognized for initiating DNA double-strand break repair via histone H2AX, p53, and Chk2 phosphorylation, ATM also functions as an intrinsic sensor of cellular oxidative stress through direct oxidation of key cysteine residues. In terminally differentiated post-mitotic cells—specifically adult rat ventricular myocytes—the enzyme maintains basal mitochondrial homeostasis, regulates metabolic flux, and governs endogenous antioxidant defenses.
Selective pharmacological modulation of this target serves as a primary experimental strategy to dissect non-canonical ATM signaling in extra-genomic pathways. The synthetic chromen-4-one derivative KU-55933 functions as a selective, ATP-competitive inhibitor of ATM kinase activity. In cell-free enzymatic assays, KU-55933 demonstrates an IC50 of approximately 13 nM against wild-type ATM, exhibiting more than 100-fold selectivity over related PIKK family members, including ATM-and-Rad3-related (ATR), DNA-dependent protein kinase (DNA-PKcs), mTOR, and class I phosphatidylinositol 3-kinases. When introduced to primary myocyte cultures, KU55933 rapidly permeates the plasma membrane to occupy the ATP-binding cleft within the kinase domain, preventing autophosphorylation at Ser1981 and blunting downstream target engagement.
Application of KU-55933 to isolated adult rat ventricular myocytes reveals an essential protective pathway governed by active ATM kinase. Under standard in vitro culture conditions, pharmacological suppression of ATM activity leads to a rapid, concentration-dependent accumulation of intracellular reactive oxygen species (ROS). Fluorometric tracking using 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) indicates that intracellular ROS generation escalates within hours of exposure to micromolar concentrations of KU55933. This oxidative flux is driven in part by the loss of ATM-dependent activation of AMP-activated protein kinase (AMPK) and reduced glucose-6-phosphate dehydrogenase (G6PD) activity, which compromises the cellular NADPH/NADP+ ratio and suppresses endogenous glutathione reduction.
The elevated ROS levels induced by KU-55933 treatment directly compromise cardiomyocyte viability through organellar damage. Excessive intracellular superoxide and hydrogen peroxide species induce lipid peroxidation of the inner mitochondrial membrane, impairing complex I and complex III electron transport chain efficiency. This damage precipitates a rapid collapse of the mitochondrial membrane potential (ΔΨm). Loss of potential triggers the opening of the mitochondrial permeability transition pore (mPTP), causing mitochondrial swelling and the release of pro-apoptotic factors—including cytochrome c and Smac/DIABLO—from the intermembrane space into the cytosol.
Following cytochrome c release, cytosolic Apaf-1 oligomerizes to assemble the functional apoptosome, recruiting and activating pro-caspase-9. Cleavage of caspase-9 initiates downstream executioner caspase-3 and caspase-7 processing. In cultured adult rat ventricular myocytes treated with KU-55933, cleavage of poly(ADP-ribose) polymerase (PARP) and annexin V/propidium iodide positivity increase proportionally with compound concentration. These biochemical events confirm that pharmacological blockade of ATM kinase transitions cardiac myocytes into programmed cell death via the intrinsic mitochondrial apoptotic cascade.
These empirical findings in adult rat ventricular myocyte models demonstrate that basal ATM kinase activity functions as an essential survival mechanism against oxidative stress. By suppressing ROS generation, maintaining mitochondrial stability, and preserving antioxidant cofactors, active ATM buffers the myocardium against pro-apoptotic stimuli. Disruption of this enzymatic node using KU55933 highlights potential cardiotoxic sensitivities when targeting ATM kinase in experimental models, underscoring the physiological requirement for baseline ATM activity in maintaining adult cardiac tissue homeostasis.
Furthermore, comparative treatment assays reveal that co-administration of exogenous antioxidant scavengers, such as N-acetylcysteine (NAC) or cell-permeable superoxide dismutase mimetics, attenuates the apoptotic response induced by KU-55933. This protective rescue confirms that elevated oxidative stress acts as the primary upstream trigger for apoptosis following ATM inhibition, rather than direct nuclear genomic toxicity alone. Consequently, the compound serves as an effective tool for mapping the redox-dependent survival nodes maintained by ATM in primary cardiac tissue.
Pharmacological Inhibition of Cardiac ATM Kinase Signaling
Copy code to add this image to your page
KU-55933 acts as a selective, ATP-competitive inhibitor of Ataxia telangiectasia mutated (ATM) kinase. In adult rat ventricular myocytes, pharmacological blockade of ATM kinase activity disrupts cellular redox buffering, driving an acute, concentration-dependent elevation of intracellular reactive oxygen species (ROS). This oxidative accumulation triggers mitochondrial membrane depolarization and cytochrome c release, subsequently activating executioner caspase-3 and inducing intrinsic cardiac myocyte apoptosis.
ATM Kinase Inhibition Elevates Myocyte Reactive Oxygen Species
In vitro administration of KU55933 to primary adult rat ventricular myocytes causes a marked increase in intracellular reactive oxygen species (ROS). Fluorometric assays demonstrate ROS accumulation within three hours of treatment at 10 µM concentrations. Baseline ATM activity regulates metabolic antioxidant responses; its acute inhibition deprives myocytes of redox-buffering capacity. Intracellular ROS levels rose nearly three-fold over untreated controls. This surge in oxidative stress occurs prior to detectable nuclear chromatin condensation. Consequently, ATM inhibition directly uncouples redox homeostasis in non-dividing cardiac tissue.
Concentration-Dependent Apoptosis in Rat Ventricular Myocytes
Pharmacological blockade of ATM kinase activity using KU55933 drives cardiac myocytes into intrinsic apoptosis. Annexin V binding assays reveal a concentration-dependent escalation in apoptotic cells between 1 µM and 10 µM compound exposure. Myocyte viability dropped sharply. Cleavage of caspase-3 increased significantly within twelve hours of exposure; executioner caspase activity confirmed irreversible commitment to cell death. Pro-survival protein expression remained insufficient to offset mitochondrial outer membrane permeabilization under these conditions. These empirical observations establish that functional ATM kinase activity is necessary to prevent oxidative stress-induced apoptosis in adult ventricular myocytes.

